Chemycal has been acquired by 3E

Learn More

Johnson & Johnson begins final trial phase for COVID-19 vaccine


Your substances

None


Sept. 23 (UPI) -- Johnson & Johnson announced Wednesday that it has begun the third and final phase of clinical trials for its COVID-19 vaccine.

CONTINUE READING ON www.upi.com

                   

Related News

Loading...